240 related articles for article (PubMed ID: 28379433)
1. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
[TBL] [Abstract][Full Text] [Related]
2. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
[TBL] [Abstract][Full Text] [Related]
3. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
[TBL] [Abstract][Full Text] [Related]
4. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis.
Iguchi A; Yamamoto S; Oda A; Tanaka K; Kazama JJ; Saeki T; Yamazaki H; Ishioka K; Suzutani T; Narita I
Clin Exp Nephrol; 2020 Aug; 24(8):725-733. PubMed ID: 32285213
[TBL] [Abstract][Full Text] [Related]
5. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
[TBL] [Abstract][Full Text] [Related]
6. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
Lin CJ; Wu V; Wu PC; Wu CJ
PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
[TBL] [Abstract][Full Text] [Related]
7. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.
Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D
Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085
[TBL] [Abstract][Full Text] [Related]
8. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
[TBL] [Abstract][Full Text] [Related]
9. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.
Bao M; Zhang P; Guo S; Zou J; Ji J; Ding X; Yu X
Front Cell Infect Microbiol; 2022; 12():639624. PubMed ID: 36237423
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.
Viaene L; Meijers BK; Bammens B; Vanrenterghem Y; Evenepoel P
Perit Dial Int; 2014; 34(1):71-8. PubMed ID: 24179107
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).
Rocchetti MT; Cosola C; di Bari I; Magnani S; Galleggiante V; Scandiffio L; Dalfino G; Netti GS; Atti M; Corciulo R; Gesualdo L
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164382
[TBL] [Abstract][Full Text] [Related]
13. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P
Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453
[TBL] [Abstract][Full Text] [Related]
14. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease.
Summers SC; Quimby JM; Isaiah A; Suchodolski JS; Lunghofer PJ; Gustafson DL
J Vet Intern Med; 2019 Mar; 33(2):662-669. PubMed ID: 30561098
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.
Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267
[TBL] [Abstract][Full Text] [Related]
16. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients.
Rossi M; Johnson DW; Xu H; Carrero JJ; Pascoe E; French C; Campbell KL
Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):860-865. PubMed ID: 26026209
[TBL] [Abstract][Full Text] [Related]
17. Effect of Vancomycin on the Gut Microbiome and Plasma Concentrations of Gut-Derived Uremic Solutes.
Nazzal L; Soiefer L; Chang M; Tamizuddin F; Schatoff D; Cofer L; Aguero-Rosenfeld ME; Matalon A; Meijers B; Holzman R; Lowenstein J
Kidney Int Rep; 2021 Aug; 6(8):2122-2133. PubMed ID: 34386661
[TBL] [Abstract][Full Text] [Related]
18. Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time.
Krieter DH; Kerwagen S; Rüth M; Lemke HD; Wanner C
Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30654454
[TBL] [Abstract][Full Text] [Related]
19. Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS.
Lin CN; Wu IW; Huang YF; Peng SY; Huang YC; Ning HC
J Food Drug Anal; 2019 Apr; 27(2):502-509. PubMed ID: 30987721
[TBL] [Abstract][Full Text] [Related]
20. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]